Notice of a collaboration agreement with Renascience, Inc. to develop antisense oligonucleotides for treating hereditary neurological intractable diseases 2024/06/24 Notice Read
We will give a presentation at the 9th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan. 2024/05/31 Event Read
We will give a presentation at “The International Cell & Gene Therapy China Summit(CGCS)” in Nanjing, China. 2024/05/14 Event Read
We will participate in the BIO International Convention in San Diego, Massachusetts, United States. 2024/05/14 Event Read
Our President & CEO, Mr. Hideaki Sato, will participate in the “TIDES US 2024” as a speaker. 2024/05/13 Event Read
Our President & CEO, Mr. Hideaki Sato, will participate in “PharmaLab Expo OSAKA 2024” as a speaker. 2024/03/01 Event Read
Notice：Luxna Biotech and Head Office for Open Innovation Business Development Strategy, Tohoku University Announce the Initiation of the Collaborative Research for Creation of Antisense Oligonucleotide for the Treatment of Hearing Loss 2023/12/22 Notice Read
